id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340474-hbcu72cm	Kaushik, Akanksha	Urticaria in the times of COVID‐19	2020-06-12		.txt	text/plain	668	62	53	2 As per one review, 88/256 (34.3%) patients across 16 studies demonstrated skin manifestations, mostly as erythematous maculopapular rash, urticaria or vesicular rash. 4 While there was a report of one COVID-19 patient presenting with urticaria and dry cough without any fever, 5 the timing of appearance of urticaria was variable, with lesions appearing before, with, as well as >48 hours after onset of fever. [6] [7] [8] [9] Although skin manifestations did not correlate with disease severity in most case reports, 2,6 the prospective This article is protected by copyright. study from Spain suggested that presence of urticaria and maculopapular lesions were associated with more severe COVID 19 illness and a higher (2%) mortality. With an eye on the reported literature, we make a few suggestions regarding urticaria in This article is protected by copyright. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection	./cache/cord-340474-hbcu72cm.txt	./txt/cord-340474-hbcu72cm.txt